Quest Diagnostics (DGX) Tops Q2 EPS by 12c; Raises Outlook
Tweet
Share
E-mail
Get Alerts DGX Hot Sheet
Price: $195.11 +0.06%
EPS Growth %: +7.6%
Financial Fact:
Income tax expense: -95M
Today's EPS Names:
OCCI, MAYS, CRMT, More
EPS Growth %: +7.6%
Financial Fact:
Income tax expense: -95M
Today's EPS Names:
OCCI, MAYS, CRMT, More
Join SI Premium – FREE
Quest Diagnostics (NYSE: DGX) reported Q2 EPS of $2.36, $0.12 better than the analyst estimate of $2.24. Revenue for the quarter came in at $2.45 billion versus the consensus estimate of $2.32 billion.
GUIDANCE:
Quest Diagnostics sees FY2022 EPS of $9.55-$9.95, versus the consensus of $9.33.
For earnings history and earnings-related data on Quest Diagnostics (DGX) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Micron surges 5.5% on blockbuster Anthropic AI deal ahead of earnings
- Playboy to buy back 16.6M shares from Fortress at $1.05 each
- Stifel Reiterates Buy Rating on FedEx (FDX) Ahead of Q4 Earnings
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
